In this episode, Daniel C. Butler, MD, and Shawn G. Kwatra, MD, discuss the practical considerations for using IL-13 inhibitors to treat patients with moderate to severe atopic dermatitis, including:

• Patient candidacy considerations
• Treatment advancement strategies that go beyond topical therapies
• The importance of patient-centered care that address patients’ fears and needs
• A detailed patient case to highlight take home points

Presenter

Daniel C. Butler, MD​
Assistant Dean Student Affairs​
University of Arizona College of Medicine – Tucson​
Tucson, Arizona

Shawn G. Kwatra, MD​
Dr. Joseph W. Burnett Endowed Professor and Chair ​
Department of Dermatology​
University of Maryland School of Medicine​
Baltimore, Maryland

Program page:
https://bit.ly/4kTP04D

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.